Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion type Assertion NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_head.
- NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion description "[Atf-2(-/-) MEFs also had a higher saturation density than wild-type cells and expressed lower levels of Maspin, the breast cancer tumor suppressor, which is also known to enhance cellular sensitivity to apoptotic stimuli.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_provenance.
- NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion evidence source_evidence_literature NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_provenance.
- NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion SIO_000772 17189429 NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_provenance.
- NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion wasDerivedFrom befree-2016 NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_provenance.
- NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_assertion wasGeneratedBy ECO_0000203 NP586097.RA6VdF6BXr3kebD85dobRdxt8m5r7xFmigS9lpfK-cYUw130_provenance.